中化国际(600500) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was CNY 18.84 billion, an increase of 8.17% compared to CNY 17.42 billion in the same period last year[6]. - Net profit attributable to shareholders for Q1 2022 was CNY 394.05 million, representing a growth of 30.33% from CNY 302.36 million in the previous year[6]. - The net profit after deducting non-recurring gains and losses was CNY 315.22 million, a decrease of 8.80% compared to CNY 345.64 million in the same period last year[9]. - Basic earnings per share for Q1 2022 were CNY 0.14, up 27.27% from CNY 0.11 in the same period last year[9]. - The company reported a 35% increase in revenue and a 66% increase in net profit attributable to shareholders when excluding the data from Jiangsu Yangnong Chemical Co., Ltd. from the previous year[9]. - The company reported a total comprehensive income of ¥672,075,835.44 for Q1 2022, down from ¥824,380,154.97 in Q1 2021, a decline of 18.43%[40]. - The net profit for Q1 2022 was a loss of ¥47,137,656.98, compared to a loss of ¥19,845,215.44 in Q1 2021, indicating a worsening performance[55]. Assets and Liabilities - The company's total assets increased by 12.63% to CNY 65.30 billion from CNY 57.97 billion at the end of the previous year[9]. - The company's total liabilities increased to ¥44,705,081,641.85 in Q1 2022, compared to ¥38,043,780,010.74 in Q1 2021, marking a rise of 17.55%[33]. - The total equity attributable to shareholders reached ¥12,643,357,270.71 in Q1 2022, up from ¥12,249,256,509.15 in Q1 2021, indicating an increase of 3.22%[33]. - The company's total assets reached ¥65,297,376,652.50 in Q1 2022, compared to ¥57,973,201,813.52 in Q1 2021, representing an increase of 12.56%[33]. - The total liabilities of the company stood at ¥35,716,787,873.50, with current liabilities accounting for ¥26,455,843,401.43[64]. Cash Flow - Cash flow from operating activities showed a significant improvement, with a net cash outflow of CNY 974.72 million, compared to a net outflow of CNY 2.55 billion in the previous year[9]. - The net cash flow from operating activities decreased primarily due to revenue growth and timely capital recovery[20]. - Cash flow from investment activities increased due to higher expenditures on engineering projects[20]. - Net cash flow from operating activities was negative CNY 974,721,203.68, an improvement from negative CNY 2,548,553,447.67 in Q1 2021[41]. - Cash inflow from financing activities was CNY 12,440,831,070.08, compared to CNY 11,448,305,212.33 in Q1 2021, reflecting an 8.7% increase[43]. - The company's cash flow from operating activities in Q1 2022 was ¥1,244,498,429.13, compared to ¥786,220,731.70 in Q1 2021, representing an increase of approximately 58.2%[55]. Current Assets and Inventory - Total current assets as of March 31, 2022, amounted to CNY 27.29 billion, up from CNY 21.45 billion at the end of 2021, representing a growth of approximately 27.5%[27]. - Cash and cash equivalents increased to CNY 4.88 billion from CNY 2.98 billion year-on-year, reflecting a growth of approximately 63.4%[27]. - Accounts receivable rose to CNY 5.13 billion, compared to CNY 3.68 billion in the previous year, indicating a growth of approximately 39.4%[27]. - Inventory increased to CNY 9.88 billion from CNY 7.59 billion, representing a growth of approximately 30.2%[27]. - The total current assets amounted to CNY 8,782,442,016.24, compared to CNY 6,334,380,050.60 in the previous year, indicating a 38.7% increase[48]. Expenses - Total operating costs for Q1 2022 were ¥18,027,272,296.67, up from ¥16,152,401,685.52 in Q1 2021, reflecting a growth of 11.56%[37]. - Research and development expenses for Q1 2022 were ¥228,777,303.03, slightly up from ¥223,415,726.06 in Q1 2021, showing a growth of 2.03%[39]. - Financial expenses in Q1 2022 amounted to ¥148,495,257.64, significantly higher than ¥10,303,540.86 in Q1 2021, reflecting a substantial increase[39]. - Operating expenses for Q1 2022 included sales expenses of ¥23,821,682.68 and management expenses of ¥81,820,363.79, which were higher than the previous year's figures[53]. - The financial expenses for Q1 2022 were ¥93,012,383.66, significantly higher than ¥16,781,020.84 in Q1 2021, marking an increase of about 453.5%[53]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 74,428, with the largest shareholder, China National Chemical Corporation, holding 54.21%[21]. - The company's total equity decreased to ¥9,913,681,872.44 in Q1 2022 from ¥9,956,417,861.88 in Q1 2021, showing a decline of about 0.4%[53].